If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARIX.L Regulatory News (ARIX)

  • There is currently no data for ARIX

Total Voting Rights

8 Feb 2022 07:20

Arix Bioscience PLC (ARIX) Total Voting Rights 08-Feb-2022 / 07:20 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


Arix Bioscience plc

 

Total Voting Rights

LONDON, 8 February 2022: Arix Bioscience plc announces that its total issued share capital at the close of business on 7 Februry 2022 comprised 135,609,653 Ordinary Shares of 0.001 pence each fully paid. This figure includes 6,428,853 Ordinary Shares which are held in Treasury, leaving a balance of 129,180,800 Ordinary Shares with voting rights.             

The above figure of 129,180,800 may be used by shareholders for the calculations by which they will determine if they are required to notify their major interest in, or a change to their major interest in, Arix Bioscience plc under the Disclosure Guidance and Transparency Rules. 

 

[ENDS]

 

 

 

 

For more information on Arix, please contact:

 

Arix Bioscience plc

+44 (0)20 7290 1050

ir@arixbioscience.com

 

Powerscourt Group

Sarah MacLeod, Ibrahim Khalil

+44 (0)20 7250 1446

arix@powerscourt-group.com

 

 

 

 


ISIN:GB00BD045071
Category Code:TVR
TIDM:ARIX
LEI Code:213800OVT3AHQCXNIX43
OAM Categories: 2.5. Total number of voting rights and capital
Sequence No.:141463
EQS News ID:1277660
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
1st Oct 20217:00 amEQSTotal Voting Rights
30th Sep 20215:30 pmEQSTransaction in own shares
29th Sep 20215:30 pmEQSTransaction in own shares
28th Sep 20215:30 pmEQSTransaction in own shares
28th Sep 20218:16 amEQSArtios Doses First Patient in Phase 1/2a Study of Polθ Inhibitor ART4215
27th Sep 20215:30 pmEQSTransaction in own shares
24th Sep 20215:30 pmEQSTransaction in own shares
23rd Sep 20215:30 pmEQSTransaction in own shares
22nd Sep 20215:30 pmEQSTransaction in own shares
21st Sep 20216:00 pmEQSTransaction in own shares
20th Sep 20215:30 pmEQSTransaction in own shares
17th Sep 20215:30 pmEQSTransaction in own shares
16th Sep 20216:00 pmEQSTransaction in own shares
15th Sep 20215:30 pmEQSTransaction in own shares
14th Sep 20215:30 pmRNSTransaction in own shares
13th Sep 20215:30 pmEQSTransaction in own shares
10th Sep 20215:30 pmEQSTransaction in own shares
9th Sep 20215:30 pmEQSTransaction in own shares
8th Sep 20215:30 pmEQSTransaction in own shares
7th Sep 20215:30 pmEQSTransaction in own shares
3rd Sep 20215:30 pmEQSTransaction in own shares
2nd Sep 20215:30 pmEQSTransaction in own shares
2nd Sep 202111:21 amEQSArix Bioscience participates in $90 million Series B financing for Disc Medicine
1st Sep 20215:30 pmEQSTransaction in own shares
1st Sep 20217:00 amEQSTotal Voting Rights
31st Aug 20215:30 pmEQSTransaction in own shares
27th Aug 20215:30 pmEQSTransaction in own shares
26th Aug 20215:30 pmEQSTransaction in own shares
25th Aug 20215:30 pmEQSTransaction in own shares
24th Aug 20215:30 pmEQSTransaction in own shares
23rd Aug 20215:30 pmEQSTransaction in own shares
20th Aug 20215:30 pmEQSTransaction in own shares
19th Aug 20215:15 pmEQSTransaction in own shares
18th Aug 20215:30 pmEQSTransaction in own shares
17th Aug 20215:45 pmEQSTransaction in own shares
16th Aug 20215:30 pmEQSTransaction in own shares
16th Aug 20217:00 amEQSDirector/PDMR Shareholding
13th Aug 20215:30 pmEQSTransaction in own shares
12th Aug 20215:30 pmEQSTransaction in own shares
12th Aug 20217:01 amEQSInterim Results for the Six Months Ended 30 June 2021
11th Aug 20215:30 pmEQSTransaction in own shares
10th Aug 20215:30 pmEQSTransaction in own shares
9th Aug 20215:30 pmEQSTransaction in own shares
6th Aug 20215:30 pmEQSTransaction in own shares
5th Aug 20215:15 pmEQSTransaction in own shares
4th Aug 20215:28 pmEQSTransaction in own shares
3rd Aug 20215:20 pmEQSTransaction in own shares
2nd Aug 20215:25 pmEQSTransaction in own shares
2nd Aug 20217:00 amEQSTotal Voting Rights
30th Jul 20215:15 pmEQSTransaction in own shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.